These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 7805080

  • 1. Preventing systemic embolism in patients with abnormal ventricular function.
    Raskob GE, Comp PC.
    Cardiol Clin; 1994 Aug; 12(3):477-85. PubMed ID: 7805080
    [Abstract] [Full Text] [Related]

  • 2. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
    Scardi S, Mazzone C.
    Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
    [Abstract] [Full Text] [Related]

  • 3. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H, Cohen M, Ezekowitz MD.
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [Abstract] [Full Text] [Related]

  • 4. Thrombosis and embolism from cardiac chambers and infected valves.
    Adams PC, Cohen M, Chesebro JH, Fuster V.
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):76B-87B. PubMed ID: 3537072
    [Abstract] [Full Text] [Related]

  • 5. Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial.
    Pérez-Gómez F, Salvador A, Zumalde J, Iriarte JA, Berjón J, Alegría E, Almería C, Bover R, Herrera D, Fernández C.
    Eur Heart J; 2006 Apr; 27(8):960-7. PubMed ID: 16330464
    [Abstract] [Full Text] [Related]

  • 6. [Acute circulatory failure caused by primary pulmonary hypertension or pulmonary embolism].
    Meyer G, Sanchez O.
    Rev Mal Respir; 2000 Feb; 17(1):51-65. PubMed ID: 10756556
    [Abstract] [Full Text] [Related]

  • 7. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 8. Use of antiplatelet agents and anticoagulants in post-myocardial infarction.
    Fiore LD, Deykin D.
    Cardiol Clin; 1994 Aug; 12(3):451-76. PubMed ID: 7805079
    [Abstract] [Full Text] [Related]

  • 9. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.
    Metz BK, Topol EJ.
    Biomed Pharmacother; 1996 Aug; 50(6-7):243-53. PubMed ID: 8952863
    [Abstract] [Full Text] [Related]

  • 10. Thromboembolism in patients with decreased left ventricular function: incidence, risk, and treatment.
    Wilensky RL, Jung SC.
    J Cardiovasc Risk; 1995 Apr; 2(2):91-6. PubMed ID: 7606656
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antithrombotic therapy in left ventricular thrombosis and systemic embolism.
    Cregler LL.
    Am Heart J; 1992 Apr; 123(4 Pt 2):1110-4. PubMed ID: 1553880
    [Abstract] [Full Text] [Related]

  • 13. Adjuvants to thrombolysis after acute myocardial infarction. Does adding antiplatelet agents, antithrombotics, or angioplasty make a difference?
    Figueredo VM, Amidon TM, Wolfe CL.
    Postgrad Med; 1994 Dec; 96(8):45-51, 54. PubMed ID: 7991477
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F, Alegría E, Berjón J, Iriarte JA, Zumalde J, Salvador A, Mataix L, NASPEAF Investigators.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1557-66. PubMed ID: 15489085
    [Abstract] [Full Text] [Related]

  • 15. Chronic left ventricular thrombi.
    Stratton JR.
    G Ital Cardiol; 1994 Mar 19; 24(3):269-79. PubMed ID: 8063062
    [No Abstract] [Full Text] [Related]

  • 16. [Prevention and treatment of left ventricular thrombi].
    Vecchio C.
    G Ital Cardiol; 1990 Aug 19; 20(8):773-8. PubMed ID: 2272427
    [No Abstract] [Full Text] [Related]

  • 17. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 19; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 18. Chronic antithrombotic therapy in post-myocardial infarction patients.
    Nagarakanti R, Sodhi S, Lee R, Ezekowitz M.
    Cardiol Clin; 2008 May 19; 26(2):277-88, vii. PubMed ID: 18407000
    [Abstract] [Full Text] [Related]

  • 19. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE.
    Rev Cardiovasc Med; 2006 May 19; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [Abstract] [Full Text] [Related]

  • 20. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
    Botto GL, Proclemer A, Luzi M, Ruffa F, Gorgoglione MG, Ferrari G.
    Ital Heart J; 2005 Mar 19; 6(3):210-5. PubMed ID: 15875511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.